Autoimmune disease-derived peripheral blood mononuclear cells (PBMCs) are isolated from donors diagnosed with autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and psoriatic arthritis. These PBMCs provide a disease-relevant immune cell population for investigating dysregulated immune responses, autoantibody production, cytokine signaling, and chronic inflammation associated with autoimmunity.

Available with donor-specific clinical and demographic data, autoimmune disease-derived PBMCs support translational research in drug development, biomarker discovery, and personalized immunology. They are particularly suited for studies of immune cell activation, gene expression profiling, and functional assays aimed at understanding disease mechanisms and therapeutic response in autoimmune conditions.